Edwin DeJesus, MD, reviews research highlights on investigational antiretroviral agents as reported at the 4th IAS Conference on HIV Pathogenesis, Treatment, and Prevention. Medscape HIV/AIDS
Chronically HIV-infected individuals show brain damage even when the disease is otherwise stable because of highly active antiretroviral therapy (HAART), according to a recent study by U.S. researchers. Reuters Health Information
Previously untreated patients with HIV had similar outcomes after once- or twice-daily combination antiretroviral therapy, according to trial results published in the April 1st Clinical Infectious Diseases. Reuters Health Information
